Prostate specific fusion protein compositions
    12.
    发明授权
    Prostate specific fusion protein compositions 失效
    前列腺特异性融合蛋白组合物

    公开(公告)号:US06395278B1

    公开(公告)日:2002-05-28

    申请号:US09352616

    申请日:1999-07-13

    IPC分类号: A61K3848

    摘要: Compositions and methods for the therapy and diagnosis of cancer, such as prostate cancer, are disclosed. Compositions may comprise one or more prostate tumor proteins, immunogenic portions thereof, or polynucleotides that encode such portions. Alternatively, a therapeutic composition may comprise an antigen presenting cell that expresses a prostate tumor protein, or a T cell that is specific for cells expressing such a protein. Such compositions may be used, for example, for the prevention and treatment of diseases such as prostate cancer. Diagnostic methods based on detecting a prostate tumor protein, or mRNA encoding such a protein, in a sample are also provided.

    摘要翻译: 公开了用于治疗和诊断癌症的组合物和方法,例如前列腺癌。 组合物可以包含一种或多种前列腺肿瘤蛋白,其免疫原性部分或编码这些部分的多核苷酸。 或者,治疗组合物可以包含表达前列腺肿瘤蛋白的抗原呈递细胞,或表达这种蛋白质的细胞特异的T细胞。 这样的组合物可用于例如预防和治疗诸如前列腺癌的疾病。 还提供了基于检测样品中前列腺肿瘤蛋白或编码这种蛋白的mRNA的诊断方法。

    Compounds for immunotherapy of prostate cancer and methods for their use
    13.
    发明授权
    Compounds for immunotherapy of prostate cancer and methods for their use 失效
    化合物用于前列腺癌的免疫治疗及其使用方法

    公开(公告)号:US06261562B1

    公开(公告)日:2001-07-17

    申请号:US09020956

    申请日:1998-02-09

    IPC分类号: A61K3900

    摘要: Compounds and methods for treating prostate cancer are provided. The inventive compounds include polypeptides containing at least a portion of a prostate tumor protein. Vaccines and pharmaceutical compositions for immunotherapy of prostate cancer comprising such polypeptides, or DNA molecules encoding such polypeptides, are also provided, together with DNA molecules for preparing the inventive polypeptides.

    摘要翻译: 提供了治疗前列腺癌的化合物和方法。 本发明化合物包括含有前列腺肿瘤蛋白质的至少一部分的多肽。 包含此类多肽的前列腺癌的免疫治疗用疫苗和药物组合物或编码此类多肽的DNA分子也与制备本发明多肽的DNA分子一起提供。